ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIO Bio Rad Laboratories Inc

282.26
0.46 (0.16%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 203,946
Bid Price
Ask Price
News (1)
Day High 283.41

Low
261.59

52 Week Range

High
431.79

Day Low 280.44
Share Name Share Symbol Market Stock Type
Bio Rad Laboratories Inc BIO NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.46 0.16% 282.26 19:00:00
Open Price Low Price High Price Close Price Previous Close
281.40 280.44 283.41 282.26 281.80
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,761 203,946 US$ 281.78 US$ 57,468,193 - 261.59 - 431.79
Last Trade Type Quantity Price Currency
18:00:00 19,381 US$ 282.26 USD

Bio Rad Laboratories Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.08B 28.52M - 2.67B -637.32M -22.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bio Rad Laboratories News

Date Time Source News Article
6/14/202412:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/13/202416:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
5/30/202408:00Business WireBio-Rad Names Anette Engelhardt Executive Vice President and..
5/23/202415:15Business WireBio-Rad’s Management to Participate in Fireside Chat During..
5/09/202415:30Edgar (US Regulatory)Form SD - Specialized disclosure report
5/08/202415:38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
5/08/202415:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/08/202413:25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
5/07/202415:18Edgar (US Regulatory)Form 8-K - Current report
5/07/202415:15Business WireBio-Rad Reports First-Quarter 2024 Financial Results
5/01/202408:00Business WireBio-Rad’s Management to Participate in Fireside Chat During..
4/26/202407:30Business WireBio-Rad Announces Life Science Group Management Changes
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BIO Message Board. Create One! See More Posts on BIO Message Board See More Message Board Posts

Historical BIO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week287.71288.94280.47283.47217,014-5.45-1.89%
1 Month296.00296.00280.47287.02211,688-13.74-4.64%
3 Months354.07360.13266.52294.96213,438-71.81-20.28%
6 Months316.35364.24266.52311.15214,435-34.09-10.78%
1 Year377.16431.79261.59328.73222,087-94.90-25.16%
3 Years602.00832.70261.59452.90192,456-319.74-53.11%
5 Years298.43832.70261.59454.63200,640-16.17-5.42%

Bio Rad Laboratories Description

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Your Recent History

Delayed Upgrade Clock